Hoxton Financial’s GSK GSK Stock Holding History

Hoxton Financial’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$81K	Hold	1,600	–	–	0.04%	116
2015 Q4	$81K	Buy	+1,600	New	+$81.6K	0.04%	106
2015 Q3	–	Sell	-13	Closed	-$1K	–	356
2015 Q2	$1K	Hold	13	–	–	﹤0.01%	316
2015 Q1	$1K	Hold	13	–	–	﹤0.01%	306
2014 Q4	$1K	Sell	13 -33	-72%	-$1.85K	﹤0.01%	325
2014 Q3	$3K	Hold	46	–	–	﹤0.01%	268
2014 Q2	$3K	Hold	46	–	–	﹤0.01%	271
2014 Q1	$3K	Sell	46 -1,716	-97%	-$116K	﹤0.01%	279
2013 Q4	$118K	Hold	1,762	–	–	0.05%	131
2013 Q3	$111K	Hold	1,762	–	–	0.11%	64
2013 Q2	$110K	Buy	+1,762	New	+$112K	0.06%	106

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Hoxton Financial's GSK Position: Q1 2016 in Review

Hoxton Financial held its GSK (GSK) position steady in Q1 2016 at 1,600 shares worth $81K. The position accounts for 0.04% of the portfolio, ranked #116.

Hoxton Financial first reported a position in GSK in Q2 2013 and has held it in 11 quarters since. The position peaked at $118K in Q4 2013. 727 funds tracked by Wall St. Rank hold GSK as of Q1 2016.

Hoxton Financial held 1,600 shares of GSK worth $81K as of Q1 2016.
Hoxton Financial left its GSK share count unchanged in Q1 2016.
GSK made up 0.04% of Hoxton Financial's portfolio in Q1 2016, its #116 holding.
Hoxton Financial first reported a position in GSK in Q2 2013 and has held it in 11 quarters since.
Hoxton Financial's GSK position peaked at $118K in Q4 2013.
727 funds tracked by Wall St. Rank held GSK as of Q1 2016.

Based on Hoxton Financial's 13F filing for Q1 2016, filed 29 Apr 2016.